Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA

Fig. 3

Results from quantitative weight loss experiments. Clot weight loss after 1 h in 5 different treatment groups (each n = 60). Group A acted as the control (clots treated only with buffered plasma). Groups B and C were treated with rt-PA (50 μg/ml), groups D and E with TNK (30 μg/ml). Groups C and E additionally received ultrasound application (2 MHz, 179 W/cm2). Values are depicted as mean relative weight loss with standard deviation from the mean. Values can be looked up in Table 1. *** p < 0.001, ** p = 0.001

Back to article page